Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali Volume 6 Issue 1 (2021)
CLINICAL FEATURES, COURSE AND DIAGNOSIS OF GUILLAIN-BARRE SYNDROME
Сабина Завкиевна Саттарова, Раъно Баходировна Азизова, Наргиза Нурмаматовна Абдуллаева, Гулноза Уткуровна Самиева
Abstract
Guillain-Barre syndrome (GBS) is a very rare autoimmune disease that is associated with demyelination of the peripheral nervous system and progressive muscle weakness that occurs mainly in previously healthy people. The incidence of GBS is 1.1-1.8 cases per 100,000 per year, and the incidence increases with age. The clinical spectrum of GBS is heterogeneous and includes acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN), and Miller Fisher Syndrome (MFS). The disease is usually characterized by a rapid onset of symmetrical limb weakness, which progresses within a few days to 4 weeks and occurs in patients of any age. In developed countries, GBS has become the most common cause of acute flaccid paralysis. Despite improved recognition and treatment, GBS continues to be a serious disease.
синдром Миллера-Фишера, острая моторная аксональная нейропатия (ОМАН), внутривенный иммуноглобулин, ганглиозидные антителаMiller-Fischer syndrome, acute motor axonal neuropathy (AMAN), intravenous immunoglobulin, ganglioside antibodiesMiller-Fisher sindromi, o'tkir motor aksonal neyropati (O’MAN), intravenoz immunoglobulin, gangliozid antitela
Metadata source: the journal's OAI-PMH archive · Sindex does not store the full text; it links to the source.